| Wael Ghalayini, MD | |
|
805 Pamplico Hwy Ste 315, Florence, SC 29505-6047 | |
| (843) 674-6460 | |
| Not Available |
| Full Name | Wael Ghalayini |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 19 Years |
| Location | 805 Pamplico Hwy Ste 315, Florence, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629360441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD-43760 (Iowa) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 85377 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Hospice Of South Carolina | Florence, SC | Hospice |
| Musc Health Florence Medical Center | Florence, SC | Hospital |
| Musc Medical Center | Charleston, SC | Hospital |
| Musc Health Marion Medical Center | Mullins, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Musc Community Physicians | 6507260668 | 698 |
News Archive
According to SDI's Vector One®: National, antiviral prescriptions rose dramatically last week to over 648,000, an increase of more than 73% in the past two weeks. Antiviral prescriptions have climbed each week since the week ending Aug. 21, but the increases in the past two weeks have been significant.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
America's biopharmaceutical research companies are working on 100 new medicines and vaccines [video] to treat and prevent HIV/AIDS and related conditions, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 1 days ago
| Entity Name | Carolina Family Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655722 PECOS PAC ID: 4587557731 Enrollment ID: O20040203000627 |
News Archive
According to SDI's Vector One®: National, antiviral prescriptions rose dramatically last week to over 648,000, an increase of more than 73% in the past two weeks. Antiviral prescriptions have climbed each week since the week ending Aug. 21, but the increases in the past two weeks have been significant.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
America's biopharmaceutical research companies are working on 100 new medicines and vaccines [video] to treat and prevent HIV/AIDS and related conditions, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 1 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
According to SDI's Vector One®: National, antiviral prescriptions rose dramatically last week to over 648,000, an increase of more than 73% in the past two weeks. Antiviral prescriptions have climbed each week since the week ending Aug. 21, but the increases in the past two weeks have been significant.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
America's biopharmaceutical research companies are working on 100 new medicines and vaccines [video] to treat and prevent HIV/AIDS and related conditions, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wael Ghalayini, MD Po Box 603898, Charlotte, NC 28260-3898 Ph: (843) 792-6200 | Wael Ghalayini, MD 805 Pamplico Hwy Ste 315, Florence, SC 29505-6047 Ph: (843) 674-6460 |
News Archive
According to SDI's Vector One®: National, antiviral prescriptions rose dramatically last week to over 648,000, an increase of more than 73% in the past two weeks. Antiviral prescriptions have climbed each week since the week ending Aug. 21, but the increases in the past two weeks have been significant.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
America's biopharmaceutical research companies are working on 100 new medicines and vaccines [video] to treat and prevent HIV/AIDS and related conditions, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 1 days ago
Dr. Brian Thomas Trezak, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 805 Pamplico Hwy, Florence, SC 29505 Phone: 843-792-1414 | |
Dr. Harry S. Allen Ii Iii, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 214 W Pine St., Florence, SC 29501 Phone: 843-661-0500 Fax: 843-661-7370 | |
Carolyn Reynolds, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2314 Fax: 843-777-5035 | |
Brinda Rakesh Chokshi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 360 N Irby St, Florence, SC 29501 Phone: 843-667-9414 Fax: 843-667-1362 | |
Francisco Xavier Barrera Echegoyen, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 360 N Irby St, Florence, SC 29501 Phone: 843-667-9414 Fax: 843-667-1362 | |
Dr. Ifeanyichukwu Madubobi Eruchalu, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 401 E Cheves St, Suite 202, Florence, SC 29506 Phone: 843-777-7863 Fax: 843-777-7873 | |
Prabal K. Guha, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 William H. Johnson Street, Suite 600, Florence, SC 29506 Phone: 843-667-1891 Fax: 843-665-2516 |